UBS Group AG

Position in LEXX — Lexaria Bioscience Corp.

CIK 1610520 ZURICH, V8

Position in LEXX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$26,300

-$14,812 QoQ

Shares Held

3,131

-10.9% QoQ

Ownership

0.189%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 31 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. LEXX ranks #414 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,450,825	$1,020,369,609
2	ROIV	Roivant Sciences Ltd.	17,466,641	$618,144,423
3	PTGX	Protagonist Therapeutics, Inc	3,399,221	$416,676,508
4	VRTX	Vertex Pharmaceuticals Inc / Ma	712,259	$353,800,411
5	MRNA	Moderna, Inc.	4,463,211	$312,558,664
6	INSM	INSMED Inc	2,584,446	$275,553,630
7	ABVX	Abivax S.A.	1,844,918	$245,853,771
8	MDGL	Madrigal Pharmaceuticals, Inc.	401,708	$215,697,109

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,300	46,966	-10.9%	Shares	Defined	2026-08-13
2026-03-31	$41,112	52,708	-85.4%	Shares	Defined	2026-05-05
2025-12-31	$222,921	361,300	+4995.9%	Shares	Defined	2026-01-29
2025-09-30	$6,756	7,090	+16.7%	Shares	Defined	2025-11-13
2025-06-30	$5,284	6,074	+5136.2%	Shares	Defined	2025-08-14
2024-12-31	$243	116	-97.4%	Shares	Sole	2025-02-14
2023-12-31	$5,665	4,532	+4477.8%	Shares	Sole	2024-02-09
2023-06-30	$72	99	-97.9%	Shares	Sole	2023-08-11
2023-03-31	$12,618	4,639	-17.1%	Shares	Sole	2023-05-12
2022-12-31	$13,766	5,596	-12.5%	Shares	Sole	2023-02-08
2022-09-30	$15,675	6,398	+53.4%	Shares	Sole	2022-11-10
2022-06-30	$12,429	4,171	+56.6%	Shares	Sole	2022-08-10
2022-03-31	$8,787	2,663	-35.6%	Shares	Sole	2022-05-16
2021-12-31	$16,660	4,134	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.